{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:28:32Z","timestamp":1787020112597,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Individuals with intellectual and developmental disabilities (IDD) living in congregated settings have increased risk of COVID-19 infection and mortality. Little is known about variant B.1.1.519 with spike mutation T478K, dominant in Mexico. We describe a linked SARS-CoV-2 B.1.1.519 outbreak in three IDD facilities in the Netherlands.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Following notification of the index, subsequent cases were identified through serial PCR group testing. Positive specimens were submitted for whole-genome-sequencing. Clinical information was gathered through interviews with staff members of the three facilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Attack rate (AR) in clients of the index facility was 92% (23\/25), total AR in clients 45% (33\/73) and in staff members 24% (8\/34). 55% (18\/33) of client cases were asymptomatic, versus 25% (2\/8) of staff members. Five client cases (15%) were hospitalized, two died (6%). Sequencing yielded the same specific B.1.1.519 genotype in all three facilities. No significant difference in median viral load was established comparing the B.1.1.519 variant with other circulating variants. The index of the linked outbreak reported no travel history or link to suspected or confirmed cases suggesting regional surveillance. Observed peak regional prevalence of B.1.1.519 during the outbreak supports this.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>AR, morbidity and mortality prior to control measures taking effect were high, probably related to the specific characteristics of the IDD setting and its clients. We assessed no evidence for intrinsic contributing properties of variant B.1.1.519. Our study argues for enhanced infection prevention protocols in the IDD setting, and prioritization of this group for vaccination against COVID-19.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-022-07121-y","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T23:57:39Z","timestamp":1644451059000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Linked nosocomial COVID-19 outbreak in three facilities for people with intellectual and developmental disabilities due to SARS-CoV-2 variant B.1.1.519 with spike mutation T478K in the Netherlands"],"prefix":"10.1186","volume":"22","author":[{"given":"Koen M. F.","family":"Gorgels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Dingemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M. J. W.","family":"van der Veer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Hackert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey Y. J.","family":"Hensels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper D. J.","family":"den Heijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieke B.","family":"van Alphen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H. M.","family":"Savelkoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian J. P. A.","family":"Hoebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"7121_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Q Li","year":"2020","unstructured":"Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199\u2013207.","journal-title":"N Engl J Med"},{"key":"7121_CR2","first-page":"157","volume":"91","author":"D Cucinotta","year":"2020","unstructured":"Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91:157.","journal-title":"Acta Biomed"},{"key":"7121_CR3","doi-asserted-by":"publisher","first-page":"103813","DOI":"10.1016\/j.ridd.2020.103813","volume":"108","author":"P Navas","year":"2021","unstructured":"Navas P, Amor AM, Crespo M, Wolowiec Z, Verdugo M\u00c1. Supports for people with intellectual and developmental disabilities during the COVID-19 pandemic from their own perspective. Res Dev Disabil. 2021;108:103813.","journal-title":"Res Dev Disabil"},{"key":"7121_CR4","doi-asserted-by":"publisher","DOI":"10.1056\/CAT.21.0051","author":"J Gleason","year":"2021","unstructured":"Gleason J, Ross W, Fossi A, Blonsky H, Tobias J, Stephens M. The devastating impact of Covid-19 on Individuals with intellectual disabilities in the United States. Innov Care Deliv. 2021. https:\/\/doi.org\/10.1056\/CAT.21.0051.","journal-title":"Innov Care Deliv"},{"key":"7121_CR5","doi-asserted-by":"publisher","first-page":"100969","DOI":"10.1016\/j.dhjo.2020.100969","volume":"13","author":"SD Landes","year":"2020","unstructured":"Landes SD, Turk MA, Formica MK, McDonald KE, Stevens JD. COVID-19 outcomes among people with intellectual and developmental disability living in residential group homes in New York State. Disabil Health J. 2020;13:100969.","journal-title":"Disabil Health J"},{"key":"7121_CR6","doi-asserted-by":"publisher","first-page":"100942","DOI":"10.1016\/j.dhjo.2020.100942","volume":"13","author":"MA Turk","year":"2020","unstructured":"Turk MA, Landes SD, Formica MK, Goss KD. Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis. Disabil Health J. 2020;13:100942.","journal-title":"Disabil Health J"},{"key":"7121_CR7","unstructured":"World Health Organization. Long-stay mental health care institutions and the COVID-19 crisis: identifying and addressing the challenges for better response and preparedness. 2020. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/333964\/WHO-EURO-2020-40745-54930-eng.pdf."},{"key":"7121_CR8","volume-title":"COVID-19 weekly epidemiological update 22: special edition: proposed working definitions of SARS-CoV-2 variants of interest and variants of concern","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. COVID-19 weekly epidemiological update 22: special edition: proposed working definitions of SARS-CoV-2 variants of interest and variants of concern. Geneva: World Health Organization; 2020."},{"key":"7121_CR9","unstructured":"Varianten van het coronavirus SARS-CoV-2. https:\/\/www.rivm.nl\/coronavirus-covid-19\/virus\/varianten. Accessed 22 Apr 2021."},{"key":"7121_CR10","unstructured":"SALUD. COVID-19 M\u00c9XICO Comunicado T\u00e9cnico Diario. https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/618441\/CP_Salud_CTD_coronavirus_COVID-19__25feb21.pdf."},{"key":"7121_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27062","author":"S Di Giacomo","year":"2021","unstructured":"Di Giacomo S, Mercatelli D, Rakhimov A, Giorgi FM. Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K. J Med Virol. 2021. https:\/\/doi.org\/10.1002\/jmv.27062.","journal-title":"J Med Virol"},{"key":"7121_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/science.abg3055","author":"N Davies","year":"2021","unstructured":"Davies N, Abbott S, Barnard R, Jarvis C, Kucharski A, Munday J, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B117 in England. Science. 2021. https:\/\/doi.org\/10.1126\/science.abg3055.","journal-title":"Science"},{"key":"7121_CR13","unstructured":"Coronavirus disease COVID-19. https:\/\/www.rivm.nl\/en\/coronavirus-covid-19\/coronavirus-disease-covid-19. Accessed 25 Mar 2021."},{"key":"7121_CR14","unstructured":"Almers W, Edwards van Muijen J, Van Houten P, Nonneman M, Pladdet I, Smalbrugge M, et al. Behandeladvies COVID-19 acute fase en nazorg. 2021. https:\/\/www.verenso.nl\/_asset\/_public\/Thema-en-projecten\/Infectieziekten\/Covid-19\/210401-COVID-19-behandel-advies-DEFINITIEF.pdf."},{"key":"7121_CR15","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/s41591-020-0997-y","volume":"26","author":"BB Oude Munnink","year":"2020","unstructured":"Oude Munnink BB, Nieuwenhuijse DF, Stein M, O\u2019Toole \u00c1, Haverkate M, Mollers M, et al. Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands. Nat Med. 2020;26:1405\u201310. https:\/\/doi.org\/10.1038\/s41591-020-0997-y.","journal-title":"Nat Med"},{"key":"7121_CR16","unstructured":"Your research: Is it subject to the WMO or not? https:\/\/english.ccmo.nl\/investigators\/legal-framework-for-medical-scientific-research\/your-research-is-it-subject-to-the-wmo-or-not. Accessed 4 June 2021."},{"key":"7121_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1017\/ipm.2020.45","volume":"37","author":"K Courtenay","year":"2020","unstructured":"Courtenay K, Perera B. COVID-19 and people with intellectual disability: impacts of a pandemic. Ir J Psychol Med. 2020;37:231\u20136.","journal-title":"Ir J Psychol Med"},{"key":"7121_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jmii.2020.05.001","volume":"54","author":"Z Gao","year":"2021","unstructured":"Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, et al. A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect. 2021;54:12\u20136.","journal-title":"J Microbiol Immunol Infect"},{"key":"7121_CR19","doi-asserted-by":"crossref","unstructured":"Goyal A, Reeves D, Schiffer JT. Early super-spreader events are a likely determinant of novel SARS-CoV-2 variant predominance. medRxiv. 2021.","DOI":"10.1101\/2021.03.23.21254185"},{"key":"7121_CR20","doi-asserted-by":"publisher","first-page":"572","DOI":"10.7326\/M20-4986","volume":"174","author":"AK Clift","year":"2021","unstructured":"Clift AK, Coupland CAC, Keogh RH, Hemingway H, Hippisley-Cox J. COVID-19 mortality risk in down syndrome: results from a cohort study of 8 million adults. Ann Intern Med. 2021;174:572\u20136.","journal-title":"Ann Intern Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07121-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07121-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07121-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T23:58:05Z","timestamp":1644451085000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07121-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7121"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07121-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-588064\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,10]]},"assertion":[{"value":"3 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In the Netherlands, research is required to undergo review by an accredited Medical Research Ethics Committee if it is subject to the Dutch Medical Research Involving Human Subjects Act (WMO). Retrospective research (that is carried out on existing patient material and\/or existing patient files) is exempt from the WMO, according to the Dutch Central Committee on Research Involving Human Subjects (CCMO) [\n                      \n                      ]. All data presented in this paper, including information obtained from affected institutions, were retrospectively retrieved from regular infectious disease control activities and were de-identified. As such, our study does not fall under the scope of the WMO and therefore is exempt from medical ethical approval. No additional administrative permissions were required to use the data as it is owned by the South Limburg Public Health Service.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}